Latest Expert Opinions

Signal
Opinion
Expert
BUY
BUY
January 13, 2020
All pharma companies face pricing pressure in a US election year, because US candidates take shots at drug pricing. Also pharma companies need to keep putting new, successful drugs. NN succeeds in putting out new diabetes drugs (they lead this product segment globally).
Show full opinionHide full opinion
Novo-Nordisk (NVO-N)
January 13, 2020
All pharma companies face pricing pressure in a US election year, because US candidates take shots at drug pricing. Also pharma companies need to keep putting new, successful drugs. NN succeeds in putting out new diabetes drugs (they lead this product segment globally).
BUY
BUY
January 13, 2020
Has an ADR? Yes. India is facing economic issues as it grows under its PM, now in his second term. HDFC is well-positioned, suffering lower loan losses than other banks like ICICI. You want to invest in India which has a huge, growing middle class.
Show full opinionHide full opinion
HDFC Bank Ltd (HDB-N)
January 13, 2020
Has an ADR? Yes. India is facing economic issues as it grows under its PM, now in his second term. HDFC is well-positioned, suffering lower loan losses than other banks like ICICI. You want to invest in India which has a huge, growing middle class.
TOP PICK
TOP PICK
January 13, 2020
An ESG play. A small-cap in the agriculture space, a GPS that helps farmers increase harvests; devices that reduce waste when you extract resources from the ground; and helping to launch internet to Uganda and Kenya. (Analysts’ price target is $34.33)
Show full opinionHide full opinion
Raven Industries (RAVN-Q)
January 13, 2020
An ESG play. A small-cap in the agriculture space, a GPS that helps farmers increase harvests; devices that reduce waste when you extract resources from the ground; and helping to launch internet to Uganda and Kenya. (Analysts’ price target is $34.33)